¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

(¿Â¶óÀÎ) 2021³â Á¦4Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2021-06-05

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
(¿Â¶óÀÎ) 2021³â Á¦4Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2021-06-05
±³À°ÀÏÀÚ : 2021-06-05
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ) 2021³â Á¦4Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѳ»°úÇÐȸ
´ã´çÀÚ : ´ëÇѳ»°úÇÐȸ
¿¬¶ôó : 02-793-4364  
À̸ÞÀÏ : kaim4364@kaim.or.kr      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 31 ½Ã°£ 45ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í »çÀüµî·Ï: (³»°úÀü°øÀÇ¡¤Àü¹®ÀÇ) 50,000¿ø / (Ÿ°ú/ºñȸ¿ø) 70,000¿ø / ´çÀϵî·Ï: (³»°úÀü°øÀÇ¡¤Àü¹®ÀÇ) 60,000¿ø / (Ÿ°ú/ºñȸ¿ø) 80,000¿ø      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 06-05  08:30~08:55 Treatment of HBV According to Recent Guidelines  À±¾ÆÀϸ°(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-05  08:55~09:20 Managemet of Liver Cirrhosis Complicatoin  ¼­¿¬¼®(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-05  09:20~09:45 Diagnosis and Management of Gallstone Disease  À±ÀçÈÆ(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-05  09:45~10:10 Diagnosis and Management of Pancreas Cystic Disease  ÀåÀçÇõ(°¡Å縯ÀÇ´ë) 
È޽Ġ06-05  10:10~10:30 È޽Ġ () 
±³À°½Ã°£ 06-05  10:30~11:00 Diagnosis and Management of Esophageal Cancer  ÀÌÁ¤ÈÆ(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-05  11:00~11:30 Diagnosis and Management of Functional Dyspepsia  ±è»ó±Õ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-05  11:30~12:00 Diagnosis and Treatment of IBS  À±Áø¿µ(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-05  12:00~12:30 Diagnosis and Treatment of Lower GI Bleeding  ±Ýº¸¶ó(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-05  08:30~09:00 Approach and Differential Diagnosis of ILD  ÀÌÀºÁÖ(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-05  09:00~09:30 Progressive Fibrosing ILD  ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-05  09:30~10:00 Treatment and Management Strategies of ILD  ¹ÚÁ¾¼±(¼­¿ïÀÇ´ë) 
È޽Ġ06-05  10:10~10:30 È޽Ġ () 
±³À°½Ã°£ 06-05  10:30~11:00 Screening & Early Diagnosis of Lung Cancer  ¹Ú¿µ½Ä(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-05  11:00~11:30 Considerations in Staging of Lung Cancer  ¾ö»ó¿ø(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-05  11:30~12:30 Optimal Treatment Strategies for Advanced Lung Cancer  ÀÌÁ¤Àº(Ãæ³²ÀÇ´ë) 
±³À°½Ã°£ 06-05  08:30~09:00 Basic Overview of Electrolyte and Acid-Base in Renal Physiology  ¹èÀºÈñ(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 06-05  09:00~09:25 The Recent Update in Sodium and Water Balance Disorder  ±è¼¼Áß(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 06-05  09:25~09:50 Potassium Homeostasis and Management of Dyskalemia in Kidney Diseases (Conclusions A KDIGO Controversies Conference)  ±è¼öÇö(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-05  09:50~10:25 Management of Calcium and Phosphate in Hemodialysis Patients  °­¿µ¼±(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-05  10:25~10:35 Q&A  () 
È޽Ġ06-05  10:35~10:50 È޽Ġ () 
±³À°½Ã°£ 06-05  10:50~11:20 Diagnosis of Metabolic Acid-Base Disorders  À̼º¿ì(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 06-05  11:20~11:45 Acid-Base Disorder in Critically ill Patients  Á¤¼ºÁø(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 06-05  11:45~12:10 Acid-Base Management in CKD Patients  ±æÈ¿¿í(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 06-05  12:10~12:20 Q&A  () 
±³À°½Ã°£ 06-05  08:30~09:15 Viral Kinetics of SARS-CoV-2 and De-Isolation Strategy  Á¤Áø¿ø(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-05  09:15~10:00 Antibody Treatment for COVID-19  ¾öÁß½Ä(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 06-05  10:30~11:10 Guidelines for Antimicrobial Stewardship  ±è½Å¿ì(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-05  11:10~11:50 Guidelines for Diagnosis and Treatment of Vertebral Osteomyelitis  ¹Ú±âÈ£(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-05  11:50~12:30 Guidelines for Asymptomatic Bacteriuria and Urinary Tract Infections  ±èÁöÀº(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-05  13:30~13:55 Cardiovascular Disease in COVID-19 Era  ±èÀÎö(°è¸íÀÇ´ë) 
±³À°½Ã°£ 06-05  13:55~14:20 SGLT-2 Inhibitors in HF  ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 06-05  14:20~14:45 Current Issue for Cardio-Oncology  ¼ÕÀϼ®(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-05  14:45~15:00 Q&A  () 
±³À°½Ã°£ 06-05  15:30~15:55 Update on Management of Valvular Heart Disease  ½ÉÁö¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-05  15:55~16:20 Current Management of Acute Coronary Syndromes  ÀÌÀåÈÆ(°æºÏÀÇ´ë) 
±³À°½Ã°£ 06-05  16:20~16:45 The Past, Present and Future of LVAD  ÃÖÁø¿À(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-05  16:45~17:10 Update on Management of Atrial Fibrillation?  ½ÉÀç¹Î(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 06-05  17:10~17:30 Q&A  () 
±³À°½Ã°£ 06-05  13:30~14:00 Genetic Insight into Parathyroid Diseases  À̽ÃÈÆ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 06-05  14:00~14:30 Use of Antiresorptive Agents for Osteoporosis Management  ±è°æ¹Î(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-05  14:30~15:00 Update of Anabolic Agents for Osteoporosis Management  ÃÖ¿ëÁØ(¾ÆÁÖÀÇ´ë) 
È޽Ġ06-05  15:00~15:30 È޽Ġ () 
±³À°½Ã°£ 06-05  15:30~16:00 Glucose Control by Continuous Glucose Monitoring System ¿¬¼ÓÇ÷´çÃøÁ¤À» ÅëÇÑ Ç÷´ç Á¶Àý ±æÀâÀÌ  ±èÀçÇö(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-05  16:00~16:30 Recent Update in the Diagnosis and Treatment of Diabetic Neuropathy ´ç´¢º´¼º ½Å°æº´ÁõÀÇ Áø´Ü°ú Ä¡·áÃÖ½ÅÁö°ß  ¿øÁ¾Ã¶(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-05  16:30~17:00 Medical Nutritional Therapy in Diabetes: A to Z ´ç´¢º´ °ü¸®ÀÇ ÀÓ»ó¿µ¾ç¿ä¹ýA to Z  Àü¼÷(°æÈñÀÇ´ë) 
±³À°½Ã°£ 06-05  17:00~17:30 Recent Update in the Management of Diabetes in Elderly Patients ³ëÀÎ ´ç´¢º´ °ü¸®ÃÖ½ÅÁö°ß  ¹ÚÁ¤Çö(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 06-05  13:30~14:00 Diffuse Large B-Cell Lymphoma  ±èÁø¼®(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 06-05  14:00~14:30 Chronic Lymphocytic Leukemia  Á¤¼ºÇö(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 06-05  14:30~15:00 Acute Myeloid Leukemia  ÀÌ¿ø½Ä(ÀÎÁ¦ÀÇ´ë) 
È޽Ġ06-05  15:00~15:30 È޽Ġ () 
±³À°½Ã°£ 06-05  15:30~16:00 Lung Cancer  ÀÌÀ±±Ô(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 06-05  16:00~16:30 Breast Cancer  ¾ÈÈñ°æ(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 06-05  16:30~17:00 Gastric Cancer  ¼ÛÀº±â(ÀüºÏÀÇ´ë) 
±³À°½Ã°£ 06-05  17:00~17:30 Colorectal Cancer  È²ÀαÔ(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 06-05  13:30~14:15 Unmet Needs for Severe Refractory Asthma in Real Practice: Can We Find the Exit?  ±èÁÖÈñ(ÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 06-05  14:15~15:00 Systemic Approach and Management in Adults with Atopic Dermatitis  ³²¿µÈñ(µ¿¾ÆÀÇ´ë) 
È޽Ġ06-05  15:00~15:30 È޽Ġ () 
±³À°½Ã°£ 06-05  15:30~16:10 Patients-Reported Drug and Food Allergy: Label or Delabel?  ±ÇÀç¿ì(°­¿øÀÇ´ë) 
±³À°½Ã°£ 06-05  16:10~16:50 Desensitization and Immunotherapy in Adults with Food Allergy: Do or Don¡¯t?  ±è¹Ì¾Ö(Â÷ÀÇ°ú´ëÇÐ) 
±³À°½Ã°£ 06-05  16:50~17:30 Drug Desensitization: Catching Up on the Updates  ±ÇÇõ¼ö(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 06-05  13:30~14:00 Novel Treatments (Biologics/tsDMARD) in Rheumatoid Arthritis  ¼­¹Ì·É(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 06-05  14:00~14:30 IgG4-Related Disease  À̽±Ù(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 06-05  14:30~15:00 Treatment of ANCA-Associated Vasculitis  È«¼®Âù(¿ï»êÀÇ´ë) 
È޽Ġ06-05  15:00~15:30 È޽Ġ () 
±³À°½Ã°£ 06-05  15:30~16:00 Pigmented Villonodular Synovitis Developing in the Knee of a Rheumatoid Arthritis Patient Mistaken as a Rheumatoid Arthritis Flare-Up  ÀÌ»ó¿±(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 06-05  16:00~16:30 2A Rare Case of Overlap Syndrome with Diffuse Systemic Sclerosis, Rheumatoid Arthritis, and Cutaneous Sarcoidosis  °í°æ¹Î(°¡Å縯°üµ¿ÀÇ´ë) 
±³À°½Ã°£ 06-05  16:30~17:00 Bertolotti¡¯s Syndrome Requiring Intervention for Lower Back Pain: Two Cases Suspected as Ankylosing Spondylitis  °­ÁÖ¿¬(ÇѾçÀÇ´ë) 
±³À°½Ã°£ 06-05  17:00~17:30 A Case of Rapid Progressive Neurosyphilis in Patient with Ankylosing Spondylitis Who Is Treating Anti-interleukin 17A Monoclonal Antibody, Secukinumab  ÀÌ»óÁø(°æºÏÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" (¿Â¶óÀÎ) 2021³â Á¦4Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2021-06-05""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2021³â ôÃß°æÀÎÁöȸ ÇÏ°èÇмú´ëȸ : 2021-06-05
´ÙÀ½±Û (¿Â¶óÀÎ) 2021³âµµ ºÎ»ê½Ã°³¿ø³»°úÀÇ»çȸ ÇÏ°è ¿Â¶óÀÎ ½ÉÆ÷Áö¾ö : 2021-06-05
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 50 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 44 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 45 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 52 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 39 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 80 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 29 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 45 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 40 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 47 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 51 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 34 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 37 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 44 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 46 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷